Site(s) of metastases-Bones Posts on Medivizor
Navigation Menu

Site(s) of metastases-Bones Posts on Medivizor

Adding everolimus to letrozole in premenopausal patients with hormone-positive advanced breast cancer

Adding everolimus to letrozole in premenopausal patients with hormone-positive advanced breast cancer

Posted by on Jun 6, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the effects and outcomes of adding everolimus (EVE; Afinitor) plus letrozole (LET; Femara) to hormonal therapy for the treatment of premenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (BC). The data showed that the combination of EVE+LET improved survival...

Read More

Evaluating the effectiveness of enzalutamide plus androgen deprivation therapy in metastatic hormone-sensitive prostate cancer by pattern of metastatic spread

Evaluating the effectiveness of enzalutamide plus androgen deprivation therapy in metastatic hormone-sensitive prostate cancer by pattern of metastatic spread

Posted by on Jan 17, 2021 in Prostate cancer | 0 comments

In a nutshell This study examined the impact of the pattern of metastatic spread on the effectiveness of enzalutamide in combination with androgen deprivation therapy (ADT) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). The data showed that the combination has good outcomes in men with bone and/or lymph node...

Read More

Can bisphosphonates improve treatment outcomes for patients with lung cancer spread to the bones?

Can bisphosphonates improve treatment outcomes for patients with lung cancer spread to the bones?

Posted by on Nov 3, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated whether zoledronate (Zometa) combined with TKI therapy is more effective than TKI therapy alone for patients with non-small cell lung cancer (NSCLC) spread to the bones. This study concluded that adding zoledronate to TKI therapy improved survival outcomes for these patients. Some background NSCLC is the most common...

Read More

Evaluating the safety of re-treatment with radium-223

Evaluating the safety of re-treatment with radium-223

Posted by on Sep 16, 2019 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the safety and effectiveness of radium-223 (Xofigo, formerly known as Alpharadin) in patients with advanced prostate cancer that has spread to the bones and who have had this treatment previously. This study found that re-treatment with radium-223 was well tolerated and with good results. Some background...

Read More

How effective is radiotherapy for the treatment of advanced prostate cancer?

How effective is radiotherapy for the treatment of advanced prostate cancer?

Posted by on Apr 13, 2019 in Prostate cancer | 0 comments

In a nutshell This study investigated the effectiveness of prostate radiotherapy (RT) in prostate cancer (PC). They found that prostate RT may improve survival in men with PC and fewer than 5 bone metastasis (cancer that has spread to the bones).  Some background Prostate cancer (PC) is a common and treatable cancer in men. One common type...

Read More

Looking for men with prostate cancer to test chemotherapy in combination with radiotherapy

Looking for men with prostate cancer to test chemotherapy in combination with radiotherapy

Posted by on Feb 23, 2019 in Prostate cancer | 0 comments

In a nutshell This trial evaluates the effectiveness of using chemotherapy in combination with radium-223 (a type of internal radiotherapy). The main outcome to be measured is overall survival. This trial is taking place in the United States. The details Prostate cancer is an uncontrolled growth of the cells which make up the prostate gland. Prostate...

Read More

Abiraterone plus prednisone therapy in men with advanced prostate cancer

Abiraterone plus prednisone therapy in men with advanced prostate cancer

Posted by on Aug 12, 2017 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the benefit of abiraterone acetate (Zytiga) plus prednisone (Deltasone) with hormone therapy in men with newly diagnosed, advanced prostate cancer. The authors concluded that adding abiraterone acetate plus prednisone to hormone therapy significantly increased overall survival and progression-free survival...

Read More

Cancer spread to the spine: Predictors of survival

Cancer spread to the spine: Predictors of survival

Posted by on Sep 12, 2016 in Breast cancer | 0 comments

In a nutshell This study examined predictors of survival for cancer patients with spinal bone metastases. Authors reported that stable and unstable spinal bone metastases had similar survival rates. However, factors predictive of survival were different between groups.   Some background When cancer spreads outside of the breast (known as...

Read More

Cancer spread to the spine: Predictors of survival

Cancer spread to the spine: Predictors of survival

Posted by on Sep 12, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined predictors of survival for cancer patients with spinal bone metastases. Authors reported that stable and unstable spinal bone metastases had similar survival rates. However, factors predictive of survival were different between groups. Some background When cancer spreads outside of the prostate (known as...

Read More

Cancer spread to the spine: Predictors of survival

Cancer spread to the spine: Predictors of survival

Posted by on Sep 12, 2016 in Lung cancer | 0 comments

In a nutshell This study examined predictors of survival for cancer patients with spinal bone metastases. Authors reported that stable and unstable spinal bone metastases had similar survival rates. However, factors predictive of survival were different between groups. Some background When cancer spreads outside of the lung (known as...

Read More